We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+8.74%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$828M
AUM Growth
-$126M
Cap. Flow
-$206M
Cap. Flow %
-24.87%
Top 10 Hldgs %
14.11%
Holding
2,030
New
460
Increased
536
Reduced
459
Closed
513

Sector Composition

Rank Sector Weight
1 Technology 17.42%
2 Healthcare 10.46%
3 Energy 9.82%
4 Consumer Discretionary 7.2%
5 Industrials 7.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XENE icon
451
Xenon Pharmaceuticals
XENE
$6.11B
$269K 0.03%
+34,928
New +$280K
COKE icon
452
Coca-Cola Consolidated
COKE
$12.7B
$268K 0.03%
15,000
+7,000
+88% +$110K
ENR icon
453
Energizer
ENR
$1.56B
$267K 0.03%
5,988
+4,859
+430% +$222K
CLVS
454
DELISTED
Clovis Oncology, Inc.
CLVS
$267K 0.03%
+6,004
New +$211K
PERY
455
DELISTED
Perry Ellis International Inc
PERY
$267K 0.03%
10,700
+5,100
+91% +$114K
DAR icon
456
Darling Ingredients
DAR
$9.46B
$266K 0.03%
20,569
-4,830
-19% -$65.4K
NPK icon
457
National Presto Industries
NPK
$987M
$266K 0.03%
2,500
+750
+43% +$69.8K
VATE icon
458
INNOVATE Corp
VATE
$165M
$266K 0.03%
4,480
+1,800
+67% +$89.1K
CRAI icon
459
CRA International
CRAI
$1.12B
$264K 0.03%
7,200
+200
+3% +$6.31K
BCR
460
DELISTED
CR Bard Inc.
BCR
$264K 0.03%
1,177
-1,029
-47% -$224K
CQH
461
DELISTED
Cheniere Energy Partners LP Holdings LLC
CQH
$260K 0.03%
11,623
+2,473
+27% +$52.6K
EGRX
462
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$259K 0.03%
3,260
+2,830
+658% +$206K
NSP icon
463
Insperity
NSP
$2.02B
$258K 0.03%
7,260
+1,926
+36% +$69.5K
PRIM icon
464
Primoris Services
PRIM
$4.49B
$258K 0.03%
11,337
+6,794
+150% +$149K
PAHC icon
465
Phibro Animal Health
PAHC
$1.41B
$257K 0.03%
+8,782
New +$240K
CSII
466
DELISTED
Cardiovascular Systems, Inc.
CSII
$257K 0.03%
+10,626
New +$261K
HAR
467
PUT
DELISTED
Harman International Industries
HAR
$256K 0.03%
+2,300
New +$222K
MTZ icon
468
MasTec
MTZ
$21.8B
$255K 0.03%
6,676
+5,580
+509% +$189K
EE
469
DELISTED
El Paso Electric Company
EE
$254K 0.03%
+5,468
New +$248K
AFAM
470
DELISTED
Almost Family Inc
AFAM
$251K 0.03%
5,684
+3,254
+134% +$133K
ERII icon
471
Energy Recovery
ERII
$446M
$250K 0.03%
+24,126
New +$290K
SAGE
472
DELISTED
Sage Therapeutics
SAGE
$250K 0.03%
+4,901
New +$231K
HA
473
DELISTED
Hawaiian Holdings, Inc.
HA
$250K 0.03%
4,380
+320
+8% +$16.3K
TUP
474
DELISTED
Tupperware Brands Corporation
TUP
$250K 0.03%
4,745
+200
+4% +$11.7K
CLBH
475
DELISTED
Carolina Bank Holdings Inc
CLBH
$250K 0.03%
9,673
+2,353
+32% +$53.1K

Similar funds

Prelude Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Prelude Capital Management held 2,030 positions worth $828M, down 13% from $953M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management withdrew a net $206M in Q4 2016, closing 513 positions and reducing 459 holdings. Its most notable exit was LinkedIn Corporation, an estimated $14.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 11% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Prelude Capital Management opened a new position in Harman International Industries worth $15.1M.

  • Prelude Capital Management's largest Q4 2016 buy was Harman International Industries: 136,256 shares worth $15.1M.
  • Prelude Capital Management added most to Mentor Graphics Corp in Q4 2016, an estimated $9.93M increase.
  • Prelude Capital Management's biggest Q4 2016 reduction was Parkway, Inc., cutting an estimated $6.18M.
  • Prelude Capital Management fully exited LinkedIn Corporation in Q4 2016, selling an estimated $14.3M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $828M portfolio in Q4 2016.
  • Prelude Capital Management opened 460 new positions and closed 513 in Q4 2016.
  • Prelude Capital Management's portfolio value fell 13% quarter-over-quarter to $828M.

Based on Prelude Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.